Chemotherapy-Induced Oral Mucositis Market: How Is Patient-Reported Outcome Technology Advancing CIOM Research?
Patient-reported outcome technology advancing CIOM research — the systematic development and validation of standardized patient-reported outcome measures (PROMs) for chemotherapy-induced oral mucositis — enabling objective, reproducible quantification of patient experience including pain severity, functional impairment (eating, speaking, swallowing), quality of life impact, and...
0 Comentários 0 Compartilhamentos 53 Visualizações 0 Anterior